Emerging Pharma Leaders
Advertisement
Advertisement
Trending on PharmExec
1
Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion
2
FDA Grants Accelerated Approval to Jemperli for MSI-H/dMMR Locally Advanced Rectal Cancer
3
Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche
4
METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies
5